Yubo International Biotech LTD 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OQB
Yubo International Biotech Limited announced a change in its independent registered public accounting firm, with HHL LLP resigning and HCL, PLLC being appointed, following HHL's prior 'going concern' explanatory paragraph.
OQB
Yubo International Biotech Limited has entered into a securities purchase agreement to issue 50.6 million Class A Common Shares to its President and CEO, converting $2.53 million in shareholder loans into equity at a premium to market price.
OQB
Yubo International Biotech replaces its independent registered public accounting firm due to the retirement of Michael T. Studer, engaging HHL LLP as the new auditor.
OQB
Yubo International Biotech has changed its independent registered public accounting firm from Michael T. Studer CPA P.C. to HHL Advisors Group, effective January 2, 2025, due to the retirement of Mr. Studer.